 |
市場調查報告書
商品編碼
1378598
冠狀病毒疫苗市場：依疫苗類型、配銷通路和地區分類Coronavirus Vaccine Market, By Vaccine Type, By Distribution Channel, By Geography |
||||||
預計2023年全球冠狀病毒疫苗市場規模為439億美元，預測期內（2023-2030年）年複合成長率為7.4%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 439億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期年複合成長率 | 7.40% | 2030年市場規模預測 | 723億美元 |
冠狀病毒感染疾病（COVID-19）是由 SARS-CoV-2 病毒引起的感染疾病。它具有高度傳染性，傳播迅速，並導致輕度至中度呼吸道疾病。疫苗生產和研發基本上包括去活化疫苗、減毒疫苗、病毒載體疫苗等「全微生物疫苗」、病毒蛋白和糖亞基組成的「次單位疫苗」以及病毒DNA和RNA遺傳物質疫苗三類。根據世界衛生組織（WHO）公佈的資料，截至2023年1月，有183種冠狀病毒疫苗處於臨床開發階段，199種處於臨床前開發階段。疫苗接種是遏制全球冠狀病毒病例數量不斷上升的最佳方法。 COVID-19 病例的增加預計將在預測期內支持市場成長。例如，根據世界衛生組織（WHO）冠狀病毒（COVID-19）每週流行病學更新，截至2021年 5月 30 日，全球冠狀病毒（COVID-19）病例超過 1.69 億例，其中死亡人數超過350萬人。主要企業積極參與增加研發活動和臨床試驗，預計將推動全球冠狀病毒疫苗市場的成長。
市場動態
疫苗行業的主要參與者致力於開發新疫苗。此外，政府增加投資以支持 COVID-19 疫苗的生產和分銷預計將推動市場成長。例如，2023年 9月 13 日，美國美國管制與預防中心（CDC）建議為 6 個月及以上的人接種新的 COVID 疫苗。政府推出此類法規預計將在預測期內推動全球冠狀病毒疫苗市場的成長。
本研究的主要特點
- 本報告詳細分析了全球冠狀病毒疫苗市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合度（年複合成長率）。
- 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球冠狀病毒疫苗市場的主要企業。
- 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的資訊。
- 全球冠狀病毒疫苗市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 相關人員可以透過用於分析全球冠狀病毒疫苗市場的各種策略矩陣來促進決策。
目錄
第1章 調查目的和假設
- 這項研究的目的
- 假設
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 市場機會
- 影響分析
- 近期產品發布
- 流行病學
- 合併、收購和合作
- 監管場景
- 主要進展
- PEST分析
第4章 全球冠狀病毒疫苗市場-COVID-19疾病的影響分析
- 經濟影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 對需求和供給的影響
第5章 全球冠狀病毒疫苗市場，依疫苗類型，2018-2030
- 去活化病毒
- 蛋白質次單元
- 非複製病毒載體
- 重複使用的疫苗
- RNA疫苗
- DNA疫苗
第6章 全球冠狀病毒疫苗市場，依配銷通路，2018-2030
- 政府通道
- 醫院和診所
- 其他
第7章 2018-2030年全球冠狀病毒疫苗市場（依地區）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第8章 競爭形勢
- 公司簡介
- Pfizer-BioNtech
- AstraZeneca
- Bharat Biotech
- Johnson &Johnson Services, Inc
- Moderna, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Sanofi SA
- Novavax, Inc.
- Symvivo
- CanSinoBIO
- CureVac AG
- Zydus Cadila
- Arcturus Therapeutics Holdings Inc.
- Entos Pharmaceuticals
第9章 章節
- 參考
- 調查方法
Global Coronavirus Vaccine Market is estimated to be valued at US$ 43.9 Bn in 2023, and is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 43.9 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 7.40% | 2030 Value Projection: | US$ 72.3 Bn |
Coronavirus disease (COVID-19) is an infectious disease that is caused by the SARS-CoV-2 virus. It is contagious and spreads quickly, and causes mild to moderate respiratory illness. The manufacturing and development of vaccine are basically of three types the whole-microbe vaccine approach which has inactivated vaccine, live-attenuated vaccine, and viral vector vaccine; the sub-unit approach which consists of protein or sugar subunit of a virus and genetic material approach vaccine that has dna or RNA of the virus. According to the data published by World Health Organization(WHO), in January, 2023, 183 corona virus vaccine are in clinical development and 199 are in pre clinical development. Vaccination is the best method to control the rising cases of coronavirus cases across the globe. The increasing number of COVID-19 cases is expected to support growth of the market over the forecast period. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths due to coronavirus (COVID-19) were reported up till May 30, 2021 globally. Key players are actively involved in increasing their research and development activities and clinical trials, and this is expected to drive the global coronavirus vaccine market growth.
Market Dynamics
Key players in the vaccine industry are focusing on the development of new vaccines. Moreover, increasing investments by government to support manufacturing and distribution of COVID-19 vaccines is expected to propel the market growth. For instance, on September 13, 2023, Centers for Disease Control and Prevention (CDC) recommended any one six months and older to get the new dose of COVID vaccine. Introduction of such regulations by government is expected to drive growth of the global coronavirus vaccine market over the forecast period.
Key features of the study:
- This report provides an in-depth analysis of the global coronavirus vaccine market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global coronavirus vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer-BioNtech, AstraZeneca, Bharat Biotech, Johnson & Johnson Services, Inc, Moderna, Inc., Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., Sanofi S.A., Novavax, Inc., Symvivo, CanSinoBIO, CureVac AG, Zydus Cadila, Arcturus Therapeutics Holdings Inc., and Entos Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global coronavirus vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronavirus vaccine market
Global Coronavirus Vaccine Market Detailed Segmentation:
- By Vaccine Type:
- Inactivated Virus
- Protein Subunit
- Non-replicating Viral Vector
- Repurposed Vaccines
- RNA Vaccine
- DNA Vaccine
- By Distribution Channel:
- Government Channel
- Hospital and Clinics
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Pfizer-BioNtech
- AstraZeneca
- Bharat Biotech.
- Johnson & Johnson Services, Inc
- Moderna, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Sanofi S.A.,
- Novavax, Inc.
- Symvivo
- CanSinoBIO
- CureVac AG
- Zydus Cadila
- Arcturus Therapeutics Holdings Inc.
- Entos Pharmaceuticals
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Coronavirus Vaccine Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Coronavirus Vaccine Market, By Vaccine Type, 2018- 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Inactivated Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Protein Subunit
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Non-replicating Viral Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Repurposed Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- RNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
6. Global Coronavirus Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Government Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Hospital and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
7. Global Coronavirus Vaccine Market, By Region, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Pfizer-BioNtech
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AstraZeneca
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bharat Biotech
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson Services, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Moderna, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sinovac Biotech Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Novavax, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Symvivo
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CanSinoBIO
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CureVac AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Zydus Cadila
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Arcturus Therapeutics Holdings Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Entos Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
9. Section
- References
- Research Methodology
- About us and Sales Contact
